Drug Metabolism Reviews

1.3k papers and 65.8k indexed citations i.

About

The 1.3k papers published in Drug Metabolism Reviews in the last decades have received a total of 65.8k indexed citations. Papers published in Drug Metabolism Reviews usually cover Pharmacology (625 papers), Molecular Biology (430 papers) and Oncology (276 papers) specifically the topics of Pharmacogenetics and Drug Metabolism (578 papers), Drug Transport and Resistance Mechanisms (241 papers) and Mechanisms of Drug-Induced Hepatotoxicity (115 papers). The most active scholars publishing in Drug Metabolism Reviews are Frederick J. Di Carlo, Harold Boxenbaum, Bernard Testa, Alexandru S. Biris and Ricardo Jorge Dinis‐Oliveira.

In The Last Decade

Fields of papers published in Drug Metabolism Reviews

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Drug Metabolism Reviews. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Drug Metabolism Reviews

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Drug Metabolism Reviews. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Drug Metabolism Reviews with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025